Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$199,815.00
Mar 1, 2021
Academia
Mathematical modeling of SARS-CoV-2 life cycle and COVID-19 vaccine response
968659
There are many vaccine candidates using other technologies that are currently in development in Canada and overseas such as instance Providence Therapeutics, Medicago, and VBI. This Project proposes a modeling framework that can be applied to test new candidates and compare to those that have been approved/distributed in Canada.
$173,000,000.00
Oct 18, 2020
For-profit organization
Medicago Inc. COVID-19
815733
The Project is in direct response to the global fight against COVID-19. The Project will be undertaken in two stages to (1) develop a plant-derived virus-like particle (VLP) vaccine for the prevention of COVID-19; and (2) establish a large-scale GMP Facility for vaccine and antibody production in Canada.
$200,000,000.00
Oct 18, 2020
For-profit organization
Medicago Inc. COVID-19
815733
The project is in direct response to the global fight against COVID-19. The project will be undertaken in two stages: (1) develop a plant-derived virus-like particle (VLP) vaccine for the prevention of COVID-19; and (2) establish a large-scale Good Manufacturing Practice (GMP) Facility for vaccine and antibody production in Canada.
$169,872,474.00
Oct 17, 2020
For-profit organization
Medicago Proposal to fill Canada's pandemic preparedness gap
815733
The Project was planned to be undertaken in two stages to (1) develop a plant-derived virus-like particle (VLP) vaccine for the prevention of COVID-19; and (2) establish a large-scale GMP Facility for vaccine and antibody production in Canada.
$1,915,000.00
Jan 1, 2019
For-profit organization
Development of a plant-based candidate combination vaccine for SARS-CoV-2 and seasonal influenza
920200
Development of a plant-derived candidate universal influenza vaccine ready for clinical development
$64,167.00
Apr 1, 2018
The genetic basis, ecological mediators, and evolutionary consequences of tradeoffs between attracting mutualists and repelling parasites in the legume genus Medicago
$1,313,019.00
Dec 13, 2017
Environmental factors controlling the production of recombinant proteins in Nicotiana benthamiana plants grown hydroponically in mobile gullies
CRDPJ
$34,000.00
May 10, 2017
Discovery research towards improving alfalfa traits
RGPIN
$371,615.00
Apr 25, 2017
Acceleration and Intensification of Cell Culture-Produced Influenza Vaccines for Rapid Response to Pandemic Situation
CHRPJ
$8,000,000.00
May 13, 2015
Monies allocated over more than one fiscal year;Repayable Contribution